Group 1: Company Overview and Strategy - Fertiglobe aims to increase its EBITDA to over $1 billion by 2030, reaffirming its growth strategy[2] - The company is advancing its low-carbon ammonia project "Harvest" and evaluating the "Baytown" project with ExxonMobil[2] Group 2: Market Outlook - The urea market is expected to remain tight due to annual demand exceeding supply, with European fertilizer producers potentially halting operations due to high energy costs[3] - Fertiglobe anticipates China's urea exports to reach 4 million tons next year, contributing to a favorable supply-demand outlook[3] Group 3: Competitive Advantages - Fertiglobe is one of the lowest-cost producers of fertilizer products globally, benefiting from low-cost natural gas as a primary feedstock[3] - The company's low-carbon ammonia products are expected to command higher prices than traditional ammonia, enhancing profit margins[3] Group 4: Risks - Potential risks include increased supply, declining fertilizer prices, project delays, and reduced customer acceptance of low-carbon products[4]

Global Energy Strategy - The report highlights an acceleration in the application of artificial intelligence in the energy sector, with ExxonMobil reporting significant improvements in seismic data processing times, reducing from months to weeks, potentially realizing over $1 billion in value [3][7] - The outlook for nitrogen fertilizer is positive, with CF Industries projecting strong demand in North America, India, and Brazil, and low global inventory levels [5][12] - The oil market is expected to face oversupply by 2026, as indicated by Shell, which notes increased crude oil reserves in China and a significant rise in in-transit crude volumes [4][9] Investment Focus - ADNOC Gas, ADNOC Drilling, and ADNOC Distribution are rated as outperform, with projected P/E ratios for 2025E at 15.7, 16.1, and 17.4 respectively [1] - Fertiglobe is also rated outperform, with a projected P/E of 25.1 for 2025E, benefiting from the positive nitrogen fertilizer outlook [1][12] - Companies like Saudi Aramco and Vestas Wind Systems are highlighted for their strong performance and positive growth outlooks, with P/E ratios of 16.4 and 18.6 for 2025E respectively [1] Key Industry Trends - The report emphasizes the importance of carbon capture in data centers, with ExxonMobil focusing on developing low-carbon data centers with over 90% carbon capture rates [8] - The liquid natural gas market is expected to see a balance in supply and demand, with Cheniere Energy forecasting a gradual decline in spot LNG prices due to new liquefaction capacity coming online [10][11] - The nitrogen fertilizer market is projected to maintain a favorable supply-demand balance, with CF Industries estimating global nitrogen fertilizer demand growth of 1-2% annually [5][12]

Investment Rating - The report assigns an "Outperform" rating to several companies including Pop Mart, Anta Sports, Huazhu Hotels, and Haidilao, while Budweiser APAC is rated "Neutral" [1]. Core Insights - The report highlights significant developments in the F&B sector, including Naixue's Tea announcing Gao Yuanyuan as its brand spokesperson and Mixue piloting a breakfast menu in select locations [6][7]. - The consumer goods trade-in program has driven sales exceeding RMB 2.5 trillion from January to November, benefiting over 360 million people [6]. - Haier Smart Home and LG Chem have established a joint laboratory to enhance their strategic cooperation in new product development [6]. Weekly Performance Summary - Key performers in the F&B sector include Tongqinglou (+9.3%) and DPC Dash (+4.6%), while underperformers include Yum China (-4.0%) and Xiaocaiyuan (-4.3%) [2][7]. - In the home appliance sector, TCL Electronics (+8.5%) and Roborock (+6.6%) showed strong performance, while Marssenger Kitchenware (-4.6%) and Zhejiang Meida (-6.9%) lagged [2][7].

Global Economic Outlook - The global economic growth rate is projected to slow to 3.1% in 2026, down from 3.2% in 2025, primarily due to rising protectionism and uncertainty[2][16]. - Global inflation is expected to decrease to 4.2% in 2025 and further to 3.7% in 2026, with significant disparities among different economies[2][17]. China Economic Forecast - China's GDP growth for the first three quarters of 2025 was 5.2%, slightly above the annual target of 5%, with a forecasted growth of approximately 4.8% in 2026[3][32]. - Structural challenges persist in the Chinese economy, including an aging population and weakened consumer spending, which may hinder long-term growth[3][32]. US Economic Outlook - The US economy has maintained a strong growth rate of 2.8% over the past two years, with a projected GDP growth of 2.3% in 2026, supported by fiscal policies and AI investments[4][34]. - Inflation in the US is expected to remain above target levels, impacting monetary policy decisions[4][34]. Asset Class Performance - Emerging market investments are anticipated to improve significantly starting in 2025, while developed markets have shown steady performance due to high profitability and AI themes[5][39]. - Gold has outperformed other assets as a hedge against inflation and currency risks, while global bond returns remain under pressure due to high interest rates[5][40]. Market Predictions - The Shanghai Composite Index is expected to rise to 5600 points in 2026, driven by improvements in economic fundamentals and corporate earnings[6][54]. - The Hang Seng Index is projected to reach 34,000 points, reflecting a broader market recovery and increased capital inflows[6][54].

[Table_Title] 研究报告 Research Report 7 Dec 2025 中国策略 China Strategy 政策窗口临近，市场反弹动能有望延续 Policy Window Approaching, Market Rebound Momentum Likely to Continue 周林泓 Amber Zhou 李加惠 Jiahui Li, CFA [Table_yemei1] 观点聚焦 Investment Focus [Table_summary] (Please see APPENDIX 1 for English summary) 上周我们认为市场整固后有望延续反弹，科技修复仍有空间。本周港股与 A 股市场缩量震荡后于周五拉升，市场开 始关注中国政策窗口；有色金属受国际金属价格大涨带动表现最强，科技中以算力为代表的相关个股也表现相对 活跃。 下周市场将面临三大关键事件：政治局会议、中央经济工作会议以及美联储议息会议，市场波动可能加大。周五 市场已开始提前交易政治局会议释放宽松货币政策与积极财政政策信号的预期。同时，市场对政策支持长期资金 入市的预期进一步升温，周五金管总局正式下 ...

Investment Rating - The report suggests a positive outlook for the new industrial sector, particularly focusing on data centers and energy infrastructure, driven by the increasing demand for AI and cloud services. Core Insights - The report highlights a significant increase in data center capacity in Europe, expected to double due to rising demand from new cloud services. In the U.S., residential electricity prices rose by 7.4% year-on-year in September, indicating a tightening energy market [1][3]. - The report emphasizes the need for regulatory clarity from FERC regarding the connection of large data centers to the grid, stressing that they should only connect when grid reliability is assured [1][3]. - The U.S. energy market is experiencing a shift, with a notable increase in electricity demand driven by industrial returns, AI data center construction, and decarbonization efforts [5][9]. Summary by Sections Global Infrastructure and Construction Equipment - Data center vacancy rates in North America have reached a historic low of 1.6%, with significant price increases for data center cabinets due to high demand and limited power supply [8]. - The U.S. Department of Energy is pushing for the construction of data centers on federal land as part of its AI strategy, which includes significant investments in energy infrastructure [9][10]. Global Electrical and Intelligent Equipment - The gas turbine price index in the U.S. increased by 5.49% year-on-year and 2.1% month-on-month as of September 2025, reflecting strong demand in the energy sector [15][17]. - The report notes that the U.S. electricity demand is expected to grow significantly, with projections indicating an increase of 15.8% by 2029 [23][27]. Global Energy Industry - The wholesale electricity prices in the U.S. have shown significant fluctuations, with the average retail electricity price reaching 14.23 cents/kWh, a 7% increase year-on-year [3][29]. - The report indicates that the U.S. is investing heavily in transmission infrastructure, with over $50 billion approved for new transmission expansions [27][28]. Global New Materials - The report tracks the uranium spot price at $75.80 per pound, with a slight decrease of 5% month-on-month, while the long-term price remains at $86.00 per pound [4]. Key Company Insights and Comments - The report recommends focusing on companies involved in AI power operations and energy equipment, such as Entergy, Talen Energy, and Oklo, as they are well-positioned to benefit from the ongoing energy transition [5][42]. - Companies like GE Vernova and Siemens Energy are expanding their manufacturing capabilities to meet the growing demand for energy infrastructure [44][45].

Investment Rating - The report maintains an "Outperform" rating for the company [1] Core Insights - The new tax policy is expected to benefit compliant leading brands, with the company poised to increase its market share in the investment gold sector [3][4] - Revenue forecasts for the company from 2025 to 2027 are projected at 26.07 billion, 28.94 billion, and 31.80 billion yuan, with growth rates of 29%, 11%, and 10% respectively [1][10] - The company's net profit attributable to shareholders is expected to be 833 million, 943 million, and 1.02 billion yuan for the same period, with growth rates of 16%, 13%, and 9% respectively [1][10] Financial Summary - Total revenue for 2025 is estimated at 26,073 million yuan, with a year-on-year growth of 28.9% [2][11] - The net profit attributable to shareholders for 2025 is projected at 833 million yuan, reflecting a growth of 15.8% [2][11] - The company maintains a high dividend payout ratio of over 75% [4] Market Dynamics - The new tax policy, effective from November 1, 2025, introduces differential VAT treatment based on the purpose of gold purchases, which is expected to increase procurement costs for non-investment gold [4][36] - The company, as a member of the Shanghai Gold Exchange, benefits from a direct procurement model that mitigates cost increases associated with the new tax policy [4][38] - The demand for investment gold is expected to rise significantly, driven by increasing gold prices and changing consumer preferences [15][26] Business Model and Strategy - The company operates a direct sales model, allowing it to maintain price advantages and capture demand from other brands [4][40] - The company is expanding its store network, with a total of 103 direct chain stores as of the first half of 2025, covering key cities [4][40] - The business strategy focuses on high-value segments, with a "smile curve" model that emphasizes upstream procurement and product design while outsourcing production [40][44]

Investment Rating - The report maintains an "Outperform" rating for ZTO Express, with a target price of 195.99 HKD based on a projected P/E of 15x for 2025 [9][10]. Core Insights - In Q3 2025, ZTO Express experienced a slowdown in parcel volume growth, with revenue reaching 11.86 billion RMB, up 11.1% YoY, and total parcel volume at 9.57 billion, up 9.8% YoY. The growth deceleration is attributed to seasonal factors and price increases affecting demand for small and low-priced parcels [10][11]. - The net profit for Q3 was 2.54 billion RMB, reflecting a 6.7% YoY increase, driven by regulatory measures that boosted prices and optimized business structure, with a notable 50% YoY increase in loose parcel volume [10][11]. - Cost efficiency continues to improve, with the per parcel cost at 0.91 RMB, up 0.09 RMB YoY. The transport cost per parcel decreased by 11.5% YoY to 0.34 RMB, benefiting from economies of scale and efficient route planning [11][12]. - The market share for ZTO Express in Q3 2025 was 19.37%, showing a slight decline but still maintaining its leadership position in the industry. Regulatory measures are expected to shift competition towards quality, benefiting established players [12]. Financial Summary - Projected net profit attributable to shareholders for 2025-2027 is 9.57 billion, 10.63 billion, and 11.93 billion RMB, respectively, with corresponding EPS of 11.89, 13.22, and 14.83 RMB [9][10]. - Revenue forecasts for 2023A, 2024A, 2025E, 2026E, and 2027E are 38.42 billion, 44.28 billion, 47.11 billion, 51.69 billion, and 57.71 billion RMB, respectively, reflecting growth rates of 9%, 15%, 6%, 10%, and 12% [4][5]. - The projected P/E ratios for the same years are 14.96, 13.82, 12.51, 11.26, and 10.03, indicating a downward trend as earnings are expected to grow [4][5].

Investment Focus - The report highlights a favorable market style for essential consumer goods in China, with several companies rated as "Outperform," including Guizhou Moutai, Wuliangye, and Yili [1]. Industry Overview - In November 2025, four out of eight tracked essential consumer sectors showed positive growth, including condiments, frozen foods, soft drinks, and dining, while four sectors, such as high-end and below-average baijiu, dairy products, and beer, experienced negative growth [3][8]. - The overall growth rate across all sectors has weakened compared to the previous month, attributed to macroeconomic conditions, structural industry conflicts, and seasonal factors [3][8]. Price Trends - In November, wholesale prices for most baijiu brands declined, with Guizhou Moutai's prices dropping by 110 to 90 yuan compared to the previous month [4][20]. - The average price for Wuliangye remained stable, while the market for high-end baijiu showed a decline in both volume and price [9][10]. Cost Analysis - The cost index for six categories of consumer goods mostly increased in November, with soft drinks and dairy products rising by 2.50% and 0.74%, respectively [4][48]. - The prices of raw materials such as paper and plastic have shown significant year-on-year changes, with paper prices increasing by 17.5% [4]. Fund Flow - As of the end of November, net inflows into Hong Kong Stock Connect reached 111.58 billion yuan, with the essential consumer sector's market capitalization share increasing by 0.32 percentage points [5]. Valuation Metrics - By the end of November, the PE historical percentile for A-share food and beverage was at 21%, with the beer sector at a low of 1% [5]. - The median valuation for leading A-share food and beverage companies remained stable at 22x, while H-share essential consumer sector PE historical percentile was at 24% [5]. Recommendations - The report suggests focusing on high-dividend stocks as a long-term strategy, particularly in the dairy sector, which is expected to recover first, and regional leaders in the baijiu market [6].

Investment Rating - The report recommends an "Outperform" rating for leading pharmaceutical and biotech companies with robust pipelines, as well as high-quality CXOs and internet healthcare firms [1]. Core Insights - The report highlights the strong performance of innovative drug leaders such as BeiGene and Innovent Biologics, which have shown significant revenue growth in Q3 2025, with BeiGene achieving USD 1.41 billion in revenue (up 41% year-on-year) and Innovent exceeding CNY 3.3 billion (up 40% year-on-year) [39][40]. - The CXO sector experienced a pullback in November, with notable declines in stocks like WuXi AppTec and Tigermed, attributed to profit-taking after strong performance in the first three quarters of 2025 and concerns over geopolitical risks [42]. - The report emphasizes the importance of upcoming clinical data readouts from major conferences such as ESMO Asia and ASH, which could serve as catalysts for stock performance [10]. Summary by Sections Top Picks - The report lists top picks including Hansoh Pharma, 3SBio, Kelun-Biotech, Innovent, Akeso, JD Health, and WuXi AppTec, all rated as "Outperform" [1][4][35]. Performance Overview - The Hong Kong stock picks portfolio gained an average of 5.2% in November 2025, outperforming the Hang Seng Healthcare Index, which declined by 0.1% [5][36]. - The top three performers in the portfolio were Hansoh Pharma (+12.9%), BeiGene (+10.2%), and Innovent (+10.0%) [5][36]. Market Trends - The innovative drug sector has shown resilience, benefiting from previous corrections and strong earnings catalysts from leading companies [39]. - The report notes that the recent implementation of key industry policies, including the 11th National Centralized Drug Procurement, has led to significant price reductions for selected products, impacting market dynamics [38]. Clinical Developments - Significant clinical progress is noted for companies like 3SBio, which is advancing its SSGJ707 (PD-1/VEGF) with Pfizer, planning to initiate multiple clinical trials [41]. - The report also highlights the potential of innovative therapies in oncology, with companies like BeiGene and Innovent expanding their product pipelines and market presence [32][40].